medicaid glp 1 The case for maintaining coverage for GLP-1s to treat obesity in Rhode Island • Rhode Island Current Did we prescribe a GLP-1

doi: 10.1016/j.neuropharm.2017.11.048

Your health is far too important to risk on unproven products

At week 12, the average loss was approximately 6%

Benefits Significant, clinically proven weight loss Reduced risk of Type 2 diabetes, high blood pressure, and cardiovascular disease Non-surgical, once-weekly injection Personalized dosing not a one-size-fits-all approach Physician-supervised by a board-certified plastic surgeon Built-in path to body contouring if needed after weight loss Best candidates for GLP-1 weight loss injections GLP-1 type medications are suitable for adults who: Have a body mass index (BMI) of 30 or higher (obesity) Have a BMI of 27 or higher (overweight) with at least one weight-related condition, such as type 2 diabetes, high blood pressure, or high cholesterol

The reason people may have quinine pills around their house is that some people take them for nocturnal leg cramps

While short-acting versions like daily injections may better control postprandial glucose levels, they have largely been replaced by long-acting alternatives such as semaglutide (Ozempic and Wegovy) and tirzepatide (Mounjaro and Zepbound), which only require weekly injections